In Vitro Activity Of Amoxycillin/Clavulanate And Ticarcillin/Clavulanate Compared With That Of Other Antibiotics Against Anaerobic Bacteria: Comparison With The Results Of The 1987 Survey

Summary

The activity of amoxycillin/clavulanate (Augmentin®) and ticarcillin/clavulanate (Timentin®) was tested against 351 strict anaerobic clinical isolates collected from September 1993 to April 1994 in eight Belgian university hospitals and compared with that of 8 other antibiotics using the NCCLS reference agar dilution procedure. Production of (J-lactamase was detected by the nitrocefin test in 48% of the isolates. At NCCLS-recommended breakpoints, more than 90% of isolates were susceptible to amoxycillin/clavulanate, ticarcillin/clavulanate, piperacillin/tazobactam, imipenem, chloramphenicol and metronidazole but only 77%, 72% and 48% to cefoxitin, clindamycin and penicillin, respectively. In comparison with the results of a similar survey conducted in 1987, no major changes in susceptibility were observed except for the susceptibility to clindamycin that declined from 83% to 72% overall, and from 83% to 66% in the B.fragilis group. Furthermore one isolate of Clostridium clostridioforme was found to produce (5-lactamase and a few B. fragilis group isolates showed reduced susceptibility to metronidazole.